Geron Corp (GERN) is not a strong buy for a beginner investor with a long-term focus at this time. While hedge funds are increasing their positions and the company has shown slight improvements in revenue and net income, the stock's technical indicators are neutral, and there are no strong positive catalysts or proprietary trading signals to support an immediate buy decision. The recent price trend and lack of significant news or analyst upgrades also suggest a wait-and-see approach.
The MACD is below 0 and negatively contracting, RSI is neutral at 47, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 1.572, with resistance at 1.679 and support at 1.465.

Hedge funds have significantly increased their buying activity by 226.92% over the last quarter.
No recent news or significant insider trading activity. Analyst price target was lowered from $4 to $3, and the stock has a 50% chance of declining in the short term based on candlestick analysis.
In Q4 2025, revenue increased by 1.01% YoY to $48,015,000. Net income improved by 13.85% YoY but remains negative at -$28,862,000. EPS remained flat at -0.04, and gross margin slightly declined to 97.28%.
TD Cowen analyst maintained a Buy rating but lowered the price target from $4 to $3 ahead of Q4 results.